Xcout Intel
NERx Biosciences, Inc.
NERx Biosciences, Inc. is a small business enterprise headquartered in Indianapolis, Indiana, dedicated to the discovery and development of targeted therapeutics for cancer.
Subscribe to see NERx Biosciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
NERx Biosciences, Inc. at a glance
NERx Biosciences, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $200,000 in October 2021. Xcout tracks 10 named people at NERx Biosciences, Inc., including Katie Pawelczak (COO, Director).
NERx Biosciences, Inc. leadership
- Katie PawelczakCOO, Director
- John TurchiCo-Founder, President and CSO, Director
- Robert FeltgenCo-Founder
- Shadia JalalChair
- Katherine MoynihanDirector
- Trent CarrierDirector
4 more named people on record for NERx Biosciences, Inc., with roles, board committees and tenure — see the full roster →
NERx Biosciences, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $200,000 | — | |
| SEC Form D filing | $850,000 | — | |
| — | $2.2M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
NERx Biosciences, Inc. competitors
A few of NERx Biosciences, Inc.'s closest competitors — see the full list of competitors and alternatives →
IpiNovyx Bio, Inc. is a biopharmaceutical company that discovers and develops targeted proteasome inhibitors to treat cancer, autoimmune, and inflammatory diseases. Utilizing a proprietary technology platform, the company focuses on advancing selective and reversible immunoproteasome inhibitors to create safer and more effective therapies for patients.
Bakx Therapeutics, Inc. is a private biotechnology company founded in 2020 and based in New York, United States. The company specializes in pre-clinical oncology drug pipelines and novel therapeutics discovery.
Halda Therapeutics is a life sciences and drug discovery company based in New Haven, Connecticut, focused on developing targeted therapeutics.
Adnexus Biotechnologies is a drug discovery and biotechnology company headquartered in Texas that focuses on delivering accessible and affordable therapeutic solutions.
NeuroX1 Inc. is a for-profit biotechnology startup founded in 2021 with headquarters in Austin, Texas, operating a target identification and drug discovery platform that utilizes proprietary technology.
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Get NERx Biosciences, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on NERx Biosciences, Inc. in Xcout Intel
- 10 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access